Lack of independent significance of a close (<1 mm) circumferential resection margin involvement in esophageal and junctional cancer

Annals of Surgical Oncology

Volumn 20, Issue 8, 2013, Pages 2727-2733

  O'Farrell, N J ^a   Donohoe, C L ^a   Muldoon, C ^a   Costelloe, J M ^a   King, S ^a   Ravi, N ^a   Reynolds, J V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CIRCUMFERENTIAL RESECTION MARGIN; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; PATHOLOGIST; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84880256409     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2899-4     Document Type: Article

References (37)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-52.
2. Forman D. Review article: oesophago-gastric adenocarcinoma - an epidemiological perspective. Aliment Pharmacol Ther. 2004;20(Suppl 5):55-60.
3. Reynolds JV, McGillycuddy E, Ravi N, et al. Modern oncologic and operative outcomes for oesophageal cancer treated with curative intent. Ir Med J. 2011;104:235-8.
4. Liu J, Xie X, Zhou C, Peng S, Rao D, Fu J. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg. 2012;41:e7-11.
5. Waraich N, Rashid F, Jan A, et al. Vascular invasion is not a risk factor in oesophageal cancer recurrence. Int J Surg. 2011;9:237-40.
6. Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250:798-807.
7. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449-57.
8. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996-9.
9. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344(8924):707-11.
10. Pathologists RCo. Dataset for the histopathological reporting of oesophageal carcinoma. In press.
11. Edge SB BD, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag, 2010.
12. Deeter M, Dorer R, Kuppusamy MK, Koehler RP, Low DE. Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg. 2009;144:618-24.
13. Pultrum BB, Honing J, Smit JK, et al. A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol. 2010;17:812-20.
14. Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48:667-70.
15. Reynolds JV, Muldoon C, Hollywood D, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2007;245:707-16.
16. Reynolds JV, Ravi N, Muldoon C, et al. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction. World J Surg. 2010;34:2821-29.
17. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
18. American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2009.
19. Sobin LH GM, Wittekind C. TMN classification of malignant tumours. 2009.
20. Reynolds JV, Donohoe CL, McGillycuddy E, et al. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. J Thorac Cardiovasc Surg. 2012;143:1130-7.e1.
21. Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg. 1993;80:1386-8.
22. Mapstone N. Minimum dataset for oesophageal carcinoma histopathology reports. London: Royal College of Pathologists; 1998.
23. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol. 2006;32:413-9.
24. Altorki NK, Skinner DB. En bloc esophagectomy: the first 100 patients. HePatogastroenterology. 1990;37:360-3.
25. Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948-55.
26. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549-5.
27. Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2008;135:1228-36.
28. van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg. 1999;15:769-73.
29. Lerut T, Coosemans W, De Leyn P, et al. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. HePatogastroenterology. 1999;46:717-25.
30. Harvin JA, Lahat G, Correa AM, et al. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg. 2012;143:412-20.
31. Verhage RJ, Zandvoort HJ, ten Kate FJ, van Hillegersberg R. How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus. Am J Surg Pathol. 2011;35:919-26.
32. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer. 2003;88:1549-52.
33. Chao YK, Yeh CJ, Chang HK, et al. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol. 2011;18:529-34.
34. Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg. 2008;95:191-4.
35. Mulligan ED, Dunne B, Griffin M, Keeling N, Reynolds JV. Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit. Eur J Surg Oncol. 2004;30:313-7.
36. Scheepers JJ, van der Peet DL, Veenhof AA, Cuesta MA. Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis EsoPhagus. 2009;22:42-8.
37. Rao VS, Yeung MM, Cooke J, Salim E, Jain PK. Comparison of circumferential resection margin clearance criteria with survival after surgery for cancer of esophagus. J Surg Oncol. 2012;105:745-9.